| Foreword | iii | ||||
| Executive Summary | iv | ||||
| Tables | xiii | ||||
| Figures | xv | ||||
| Abbreviations | xvi | ||||
| Acknowledgments | xix | ||||
| 1 | Introduction | 1 | |||
| 1.1 | Background | 1 | |||
| 1.2 | Development and production of CCP | 1 | |||
| 1.3 | Reported health effects | 2 | |||
| 1.4 | Information sources and types | 4 | |||
| 2 | The Technology of CCP | 5 | |||
| 2.1 | How CCP works | 5 | |||
| 2.2 | CCP production | 5 | |||
| 2.3 | Microcapsule production | 6 | |||
| 2.4 | CCP production process | 7 | |||
| 2.5 | Forms production | 8 | |||
| 2.6 | Other forms and variations of CCP technology | 8 | |||
| 2.7 | Desensitizing inks | 9 | |||
| 2.8 | Summary of chemical components of CCP | 9 | |||
| 2.9 | Brand names or trademarks for CCP | 12 | |||
| 3 | Exposure | 13 | |||
| 3.1 | Introduction | 13 | |||
| 3.2 | Exposure data | 13 | |||
| 3.2.1 | Published studies | 13 | |||
| Jujo Paper Company, Ltd. 1979 | 13 | ||||
| Molhave and Grunnet 1981 | 13 | ||||
| Gothe et al. 1981 and Norback et al. 1983b | 16 | ||||
| Gockelet al. 1981 | 16 | ||||
| Chrostek and Moshell 1982 | 16 | ||||
| Norback et al. 1983b | 16 | ||||
| Norback and Gothe 1983 | 17 | ||||
ix
